REQUEST A DEMO
Total
USD $0.00
Search more companies

Neopharma Biotech Asia Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Neopharma Biotech Asia Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Neopharma Biotech Asia Sdn. Bhd distributes In Vitro Diagnostic Test Kits in Malaysia. The company offers Rapid In Vitro Diagnostic Test Kits under proprietary brand names "SENSATEST" and "NEOTEST," focusing on areas such as fertility, infectious disease, sexual transmitted disease, drug of abuse, and urinalysis reagent test. Neopharma's target market includes medical professionals and individuals seeking home-use diagnostic tests. Neopharma has developed and utilized various technologies for their diagnostic products, including immunochromatographic assays and reverse transcription loop-mediated isothermal amplification (RT-LAMP)

Headquarters
Unit B-G-3 Boulevard 51, Jalan 51A/241, Seksyen 51A
Petaling Jaya; Selangor; Postal Code: 46100

Contact Details: Purchase the Neopharma Biotech Asia Sdn. Bhd. report to view the information.

Website: http://www.neopharmaasia.com

Basic Information
Outstanding Shares:
Purchase the Neopharma Biotech Asia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Neopharma Biotech Asia Sdn. Bhd. report to view the information.
Incorporation Date:
April 07, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
48%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Neopharma Biotech Asia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
23342.55%
Total operating revenue
23342.55%
Operating profit (EBIT)
17086.72%
Net Profit (Loss) for the Period
13609.17%
Total assets
954.84%
Total equity
N/A
Operating Profit Margin (ROS)
-6.37%
Net Profit Margin
-9.92%
Return on Equity (ROE)
N/A
Quick Ratio
2.98%
Cash Ratio
2.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?